ʽ-1-()[h(hun)-1,3-]-4- Ӣ 1-methylsulfonylspiro[2H-indole-3,4'-cyclohexane]-1'-carboxylic acid ʽ C15H19NO4S 309.38100 |(zh) 309.10300 PSA 83.06000 LogP 3.12460
؛̖ | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0112213 | 100mg |
1
|
ԃr(ji) |
Q-0112213 | 250mg |
1
|
ԃr(ji) |
Q-0112213 | 500mg |
1
|
ԃr(ji) |
Q-0112213 | 1g |
1
|
ԃr(ji) |
Q-0112213 | 5g |
1
|
ԃr(ji) |

ʽ-1-()[h(hun)-1,3-]-4-
Ӣ 1-methylsulfonylspiro[2H-indole-3,4'-cyclohexane]-1'-carboxylic acid
ʽ C15H19NO4S
309.38100
|(zh) 309.10300
PSA 83.06000
LogP 3.12460
P(gun)a(chn)Ʒ
2--3--5- CAS:124432-70-8
ɳs|(zh)C(}}) CAS:1243308-37-3
RN486 CAS:1242156-23-5
1H--3- CAS:1239363-47-3
(R)-(-)-4-sˮ CAS:123750-60-7
4--3,5-S CAS:123688-59-5
Prulifloxacin CAS:123447-62-1
27--99--9H- CAS:1229603-71-7
h(hun)ϩïF CAS:12260-67-2
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
;
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖ | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ CEP-40783,CAS1437321-24-8 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ CEP-40125;RXDX-107,CAS1456608-94-8 ^N/A N/A Hʹ
-
1-(3-(S)-4-)ͪ Ӣ 1-(4-methoxy-3-phenylmethoxyphenyl)ethanone ʽ C16H16O3 256.29600 |(zh) 256.11000
-
1-h(hun)-4-(4-(2-)-1-)-2--2-3-ϩ-1-ͪ Ӣ (E)-1-cyclohexyl-4-[4-(2-methoxyphenyl)piperazin-1-yl]-2-methyl-2-phenylbut-3-en-1-one ʽ C28H36N2O2 432.59800 |(zh) 432.27800 PSA 32.78000